SCHEMBL2926152

SCHEMBL2926152

COC(=O)Cc1cc(C)c(O)c(C)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 1/20 0.66
ALDH1A1 P00352 2/20 0.50
GAA P10253 2/20 0.50
GFER P55789 1/20 0.50
CYP4F2 P78329 1/20 0.47
CYP4A11 Q02928 1/20 0.47
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HMGB1 P09429 1/20 0.43
CXCL12 P48061 1/20 0.43
SLC7A5 Q01650 1/20 0.41
HPGD P15428 2/20 0.40
MAPT P10636 1/20 0.40
TSHR P16473 1/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
PTGS1 P23219 1/20 0.39
PTGS2 P35354 1/20 0.39
ALOX5 P09917 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7069525 0.88 HSP90AB1 (0.56) HSP90AB1ALDH1A1GAAGFERCYP4F2
SCHEMBL2927454 0.88 HSP90AB1 (0.56) HSP90AB1ALDH1A1GAAGFERCYP4F2
SCHEMBL13176152 0.88 HSP90AB1 (0.64) HSP90AB1ALDH1A1GAAGFERCYP4F2
SCHEMBL21891794 0.83 HSP90AB1 (0.75) HSP90AB1ALDH1A1GAAGFERCYP4F2
SCHEMBL25281597 0.82 HSP90AB1 (0.58) HSP90AB1ALDH1A1GAAGFERCYP4F2
SCHEMBL12368043 0.82 CYP4Z1 (0.46) HSP90AB1ALDH1A1GAASMN1; SMN2HMGB1
SCHEMBL8204330 0.82 HSP90AB1 (0.68) HSP90AB1ALDH1A1GAAGFERCYP4F2
SCHEMBL24133044 0.81 HSP90AB1 (0.56) HSP90AB1ALDH1A1GAAGFERCYP4F2
SCHEMBL24132737 0.81 HSP90AB1 (0.56) HSP90AB1ALDH1A1GAAGFERCYP4F2
SCHEMBL5992538 0.81 PTGS1 (0.44) HSP90AB1ALDH1A1GAACYP4F2CYP4A11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE46024-E1 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. (US) 2016-06-07 US disclosed
US-RE46024-E1 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. (US) 2016-06-07 US disclosed
US-RE46024-E1 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. (US) 2016-06-07 US disclosed
US-20130165355-A1 Hydroxychroman Derivatives As Engine Oil Antioxidants THE LUBRIZOL CORPORATION (US) 2013-06-27 US disclosed
US-8461235-B2 Use of polymer powder containing UV absorber for the stabilisation of polymers against the effects of UV radiation BASF SE (DE) 2013-06-11 US disclosed
US-8048831-B2 Dispersant reaction product with antioxidant capability AFTON CHEMICAL CORPORATION (US) 2011-11-01 US disclosed
US-7807674-B2 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. (US) 2010-10-05 US disclosed
US-7807674-B2 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. (US) 2010-10-05 US disclosed
US-7807674-B2 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. (US) 2010-10-05 US disclosed
EP-2230906-A1 NANOPARTICULATE ANIDULAFUNGIN COMPOSITIONS AND METHODS FOR MAKING THE SAME Elan Pharma International Limited (IE) 2010-09-29 EP disclosed
US-20080318813-A1 Dispersant reaction product with antioxidant capability AFTON CHEMICAL CORPORATION 2008-12-25 US disclosed
US-7452882-B2 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. (US) 2008-11-18 US disclosed
US-7452882-B2 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. (US) 2008-11-18 US disclosed
US-7452882-B2 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. (US) 2008-11-18 US disclosed
EP-1919878-A1 PYRIDAZINONE DERIVATIVES AS THYROID HORMONE RECEPTOR AGONISTS F. Hoffmann-Roche AG (CH) 2008-05-14 EP disclosed
US-20070032494-A1 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. 2007-02-08 US disclosed
US-20070032494-A1 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. 2007-02-08 US disclosed
US-20070032494-A1 Thyroid hormone analogs HOFFMANN-LA ROCHE INC. 2007-02-08 US disclosed
WO-2007009913-A1 PYRIDAZINONE DERIVATIVES AS THYROID HORMONE RECEPTOR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-01-25 WO disclosed
WO-2007009913-A1 PYRIDAZINONE DERIVATIVES AS THYROID HORMONE RECEPTOR AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070032494-A1 Thyroid hormone analogs THRA, THRB, TPO HSP90AB1 854/4885ALDH1A1 991/4885GAA 2148/4885
US-20080318813-A1 Dispersant reaction product with antioxidant capability PRUNE1, LPO, COMT HSP90AB1 4101/4885ALDH1A1 1297/4885GAA 2881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.